iCAD to Present at UBS Global Life Sciences Conference

Thursday, September 20, 2007 General News J E 4
NASHUA, N.H., Sept. 19 iCAD, Inc.(Nasdaq: ICAD), an industry-leading provider of Computer-Aided Detection (CAD)solutions for the early identification of cancer, today announced that KenFerry, Chief Executive Officer, and Darlene Deptula-Hicks, Executive VicePresident and Chief Financial Officer of iCAD, will present a corporate updateat the UBS Global Life Sciences Conference on Wednesday, September 26th at1:00 p.m. (Eastern Daylight Time) at the Grand Hyatt New York.

The presentation will be webcast live and archived for replay on the"Investors" section of the company's Web site at

About iCAD, Inc.

iCAD, Inc. (Nasdaq: ICAD) is an industry-leading provider of Computer-Aided Detection (CAD) solutions that enable healthcare professionals to betterserve patients by identifying pathologies and pinpointing cancer earlier. iCADoffers a comprehensive range of high-performance, upgradeable CAD systems forthe high, mid and low volume mammography markets. iCAD is entrusted with thetask of early cancer detection by over one thousand women's healthcare centersworldwide. For more information, call +1 877 iCADnow or visit

For iCAD, contact Darlene Deptula-Hicks, EVP and CFO at 603-882-5200 x7944or via email at

For iCAD Investor Relations, contact Anne Marie Fields ofLippert/Heilshorn & Associates at 212-838-3777 x6604 or via email

For iCAD Public Relations, contact Wendy Ryan of Schwartz Communicationsat 781-684-0770 or via email at



You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Alfacell Corporation to Present at UBS Global Life...
National Survey Reveals One-Third of Hispanic Pare...